Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -20.00 (-0.76%)
Bid:
2,621.00
Ask:
2,625.00
Spread: 4.00 (0.153%)
Market Cap: £23.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Transaction in Own Shares

26 Jun 2025 07:00

RNS Number : 4337O
Experian plc
26 June 2025
 

Experian plc

 

Transaction in Own Shares

 

 

26 June 2025 - Experian PLC, the global information services company (the "Company"), hereby notifies the market, in conformity with Listing Rule 9.4.6R, of the following: -

 

Further to the announcement by the Company on 16 June 2025 of a share repurchase programme, the Company announces that it has purchased its ordinary shares of 10 US cents each ("Shares") on the London Stock Exchange through J.P. Morgan Securities plc, as follows:

 

Date and time of purchase:

 

25 June 2025 - 16:46

Number of Shares purchased (aggregate volume):

 

30,142

Lowest price per share: 

 

3,834.0000 pence

Highest price per share:

 

3,900.0000 pence

Weighted average price:

 

3,869.9526 pence

The Shares purchased will initially be held as treasury shares. Following this purchase, the Company holds 54,247,646 Shares in treasury. Since announcing the share repurchase programme, the Company has purchased 379,765 Shares. The total number of Shares in issue (excluding treasury shares) following this announcement is 918,743,673.

 

All transactions under this programme will be published on the Company's website (www.experianplc.com) on a weekly basis.

 

Contact:

 

Experian

Claire Murphy

Deputy Company Secretary

+353 (0) 87 421 3311

 

About Experian

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 23,300 people across 32 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
POSKZGZVKKNGKZM
Date   Source Headline
30th Apr 20193:26 pmRNSTotal Voting Rights
10th Apr 20191:17 pmRNSAdditional Listing
4th Apr 20192:38 pmRNSIrrevocable and non-discretionary arrangement
29th Mar 20192:36 pmRNSTotal Voting Rights
25th Mar 20195:08 pmRNSTransaction in Own Shares
19th Mar 20194:22 pmRNSBlock listing Interim Review
14th Mar 20195:22 pmRNSTransaction in Own Shares
12th Mar 20195:33 pmRNSTransaction in Own Shares
28th Feb 20192:38 pmRNSTotal Voting Rights
27th Feb 20197:49 amRNSAmended: Update on proposed ClearScore acquisition
27th Feb 20197:00 amRNSUpdate on proposed ClearScore acquisition
20th Feb 201911:19 amRNSAdditional Listing
25th Jan 201911:00 amRNSIssue of Notes
23rd Jan 20199:15 amRNSAdditional Listing
17th Jan 20197:00 amRNSTrading update, third quarter
11th Jan 20195:52 pmRNSFirst interim dividend
3rd Jan 20194:56 pmRNSTransaction in Own Shares
2nd Jan 201911:02 amRNSShare repurchase programme - Correction
31st Dec 201812:45 pmRNSShare repurchase programme
31st Dec 201811:48 amRNSTotal Voting Rights
21st Dec 20185:02 pmRNSTransaction in Own Shares
20th Dec 20185:03 pmRNSTransaction in Own Shares
19th Dec 20185:04 pmRNSTransaction in Own Shares
14th Dec 20182:49 pmRNSDirectorate Change
13th Dec 20184:53 pmRNSElections for first interim dividend
11th Dec 201812:04 pmRNSExperian signs new Revolving Credit Facility
10th Dec 20181:30 pmRNSExperian agrees to acquire Compuscan
6th Dec 20181:47 pmRNSAdditional Listing
30th Nov 20183:34 pmRNSTotal Voting Rights
28th Nov 20187:03 amRNSUpdate on proposed ClearScore acquisition
13th Nov 20187:00 amRNSHalf-Yearly Financial Report
12th Nov 20185:26 pmRNSTransaction in Own Shares
6th Nov 20185:24 pmRNSTransaction in Own Shares
5th Nov 20186:12 pmRNSTransaction in Own Shares
31st Oct 20183:32 pmRNSTotal Voting Rights
30th Oct 20185:36 pmRNSTransaction in Own Shares
29th Oct 20186:02 pmRNSTransaction in Own Shares
23rd Oct 20185:47 pmRNSTransaction in Own Shares
22nd Oct 20186:01 pmRNSTransaction in Own Shares
16th Oct 20186:11 pmRNSTransaction in Own Shares
15th Oct 20186:16 pmRNSTransaction in Own Shares
10th Oct 20185:44 pmRNSTransaction in Own Shares
10th Oct 20189:10 amRNSAdditional Listing
9th Oct 20186:29 pmRNSTransaction in Own Shares
8th Oct 20184:43 pmRNSIrrevocable and non-discretionary arrangement
5th Oct 20185:59 pmRNSTransaction in Own Shares
4th Oct 20185:40 pmRNSTransaction in Own Shares
28th Sep 20183:21 pmRNSTotal Voting Rights
19th Sep 20185:30 pmRNSTransaction in Own Shares
18th Sep 20185:43 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.